Oral Doxycycline for Mild Thyroid Eye Disease

Jiawei Zhao,Bita Esmaeli

DOI: https://doi.org/10.1001/jamaophthalmol.2022.3787

IF: 8.253

2022-01-01

JAMA Ophthalmology

Abstract:Yuan Pan, MD, PhD; Yu-Xi Chen, MD, PhD; Jian Zhang, MS; Miao-Li Lin, MD, PhD; Guang-Ming Liu, MD, PhD; Xue-Liang Xu, MD; Xian-Qun Fan, MD, PhD; Yong Zhong, MD, PhD; Qing Li, MD; Si-Ming Ai, MD; Wen Xu, MD, PhD; Jia Tan, MD; Hui-Fang Zhou, MD, PhD; Dong-Dong Xu, MD; Hui-Ying Zhang, MS; Bei Xu, MS; Sha Wang, MD; Jun-Jie Ma, MD; Shuo Zhang, MD, PhD; Lin-Yang Gan, MD; Jian-Tao Cui, MD; Li Li, MS; Yan-Yan Xie, MD; Xinxing Guo, MD, PhD; Nathan Pan-Doh, BS; Zhuo-Ting Zhu, MD, PhD; Yao Lu, MD; Yu-Xun Shi, MD; Yi-Wen Xia, BS; Zuo-Yi Li, MD; Dan Liang, MD, PhD